Arvinas, Inc.

ARVN · Healthcare

$9.28

Markedsværdi: 598.76M USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Arvinas, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire3. sep. 2026, 20.01

Arvinas to Participate in Upcoming Investor Conferences

Zacks3. sep. 2026, 15.50

Can KT-621 Mark a Turning Point for Kymera Therapeutics?

GlobeNewswire1. sep. 2026, 20.01

Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires10. aug. 2026, 09.40

Morgan Stanley Adjusts Price Target on Arvinas to $10 From $11, Maintains Equalweight Rating

Zacks6. aug. 2026, 16.00

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know